EP4 receptor agonist 3

Compound 3 is a selective EP4 receptor agonist used in research. It is a valuable tool for studying inflammatory bowel disease (IBD) mechanisms, particularly in preclinical models like DSS-induced murine colitis, facilitating both in vitro receptor characterization and in vivo efficacy studies.